Evidence map›Paper›PMID 25803767›Full record

ArticleJournal of managed care & specialty pharmacy2015

Role of pharmacy services in accountable care organizations.

Carrie H Colla, Valerie A Lewis, Brendin R Beaulieu-Jones, Nancy E Morden

Abstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Associations Between ACO Enrollment Status and Drug and Nondrug Costs Among Older Adults Newly Diagnosed With ADRD.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Optimization of Medication Use at Accountable Care Organizations.Journal of managed care & specialty pharmacy · 2017
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carrie H CollaThe Dartmouth Institute for Health Policy Clinical Practice,35 Centerra Pkwy., Lebanon, NH 03766. carrie.h.colla@dartmouth.edu.
Valerie A Lewis
Brendin R Beaulieu-Jones
Nancy E Morden

Funding

SYNERGY: The Dartmouth Center for clinical and Translational ScienceUL1TR001086 · NCATS · DARTMOUTH COLLEGE · PI GREEN, ALAN I · 2013 to 2017
$18.3M
Outcomes Calculators for Informed Decision Making in Back SurgeryP60AR062799 · NIAMS · DARTMOUTH COLLEGE · PI TOSTESON, ANNA N. A. · 2012 to 2016
$6.1M
SYNERGY: The Dartmouth Center for clinical and Translational ScienceKL2TR001088 · NCATS · DARTMOUTH COLLEGE · PI GREEN, ALAN I · 2013 to 2017
$3.3M
Learning from Medicare Payment Reform: Economic Effects of ACO IncentivesR33AG044251 · NIA · DARTMOUTH COLLEGE · PI COLLA, CARRIE HOVERMAN · 2014 to 2016
$1.5M
The Risk of Polypharmacy-related Fracture in Older AdultsK23AG035030 · NIA · DARTMOUTH COLLEGE · PI MORDEN, NANCY E · 2011 to 2013
$416k
NCATS NIH HHS KL2 TR001088NCATS NIH HHS UL1 TR001086NIAMS NIH HHS P60 AR062799NIA NIH HHS K23 AG035030NIA NIH HHS K23AG035030NIA NIH HHS R33 AG044251
6 · The paper itself

Abstract

backgroundThe accountable care organization (ACO) model being adopted across the United States aims to improve patient care and reduce costs. Little is known about whether commercial ACO contracts include accountability for prescription drug spending or how ACOs are engaging outpatient pharmacies and managing prescription drug use.

objectiveTo explore how ACOs are addressing drug spending and pharmacy services-a potentially important determinant of quality and total spending.

methodsWe used data from 2 waves of the National Survey of Accountable Care Organizations (N = 270), a survey completed by ACOs that were established prior to July 2013. ACO executives were asked about ACO engagement of pharmacy services, pharmacy-related health information technology capabilities, and ACO accountability for prescription drug spending.

resultsAmong ACOs with commercial contracts, 77% reported being held responsible for prescription spending by their largest contract. Considering all ACOs (Medicare, Medicaid, and/or commercial contracts), 45% reported at least 1 contract included prescription drug spending responsibility. Nearly half of ACOs reported a formal relationship with a pharmacy; 26% included a pharmacy within the ACO; and 19% had contracted pharmacy services. On average, compared with those that do not, ACOs that engage pharmacies have a broader range of services and provider types, commercial and public contracts, and greater experience with payment reform.

conclusionsManagement of pharmacy services and prescription spending will likely influence commercial ACO contract success. Given the broad potential impact of prescription use on overall spending and quality, payers might encourage integration of pharmacy services in ACOs through prescribing quality and prescription spending performance measures.

Indexed as

Pharmaceutical ServicesAccountable Care OrganizationsHumansPatient CareSurveys and QuestionnairesUnited States

Identifiers

PMID25803767
PMCPMC4462340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.